Gsk Share Discussion Threads

[che7win] 09/11/2017 09:48

Because its already fallen 150p in the past couple of weels and is trending up - the dividend ex-div date is ignored by the good news over the past few days.

[jbfnfn] 09/11/2017 09:46

Simple question. It's XD today. Why isn't the price 19p lower than yesterday?

[woodhawk] 09/11/2017 09:37

Lovely stuff - I always seem to do well with this share.

[che7win] 09/11/2017 09:14

19p dividend to boot.

[gbh2] 09/11/2017 09:03

What a difference a day makes :)

[tradermichael] 09/11/2017 08:59

Yes, for sure ..... another 19p/share in the bag ..... ;0)

[stevenrevell] 09/11/2017 08:52

Is it xdiv today ta

[ny boy] 09/11/2017 08:45

Going up on ex div day is encouraging!

[essentialinvestor] 09/11/2017 08:34

Biomass news helpful as mentioned.

[ianood] 09/11/2017 07:46

Hikma and Vectura still struggling with FDA on Clinical Endpoint for Advair generic

[cyberian] 09/11/2017 00:05

equiv.1391p at close WS tonight so maybe going xd tomorrow will not be too bad and that the recovery may continue.

[essentialinvestor] 08/11/2017 15:39

Emma sounding effusive!.

If there had not been at least some bounce today before the XD,
it would have been dire!.

[supermarky] 08/11/2017 15:32

It's going up because supermarky has bought!

[bluemango] 08/11/2017 14:27

Good appointment in Hal Barron, and the market seems to like it.

[cyberian] 08/11/2017 14:24

A very dignified exit by R&D top man and executive director (leaving March 2018), and his replacement who joins on January 1st 2018, with tremendous experience and expertise...he appears highly regarded and hence the almost immediate rally in the share price Great news

[tim 3] 08/11/2017 14:21

Well they seem to like the director change or maybe just an excuse to rally will take it either way!

[tradermichael] 08/11/2017 14:21

Wow, 20p jump upwards in 20 minutes there, supermarky and others calling it lower??

[philanderer] 08/11/2017 14:15

8 November 2017 | 12:40pm

StockMarketWire.com -

Beaufort Securities today reaffirms its buy investment rating on GlaxoSmithKline PLC [LON:GSK] and cut its price target to 1450p (from 1800p).

[supermarky] 08/11/2017 14:11

Looks like 1300 at least will be tested. I don't really care though. This is already bombed after tge recent dive and I'm taking divis enroute. One to hold and take quarterly payment. At a discount. Could fall further in which case I will buy more in tranches

[cyberian] 08/11/2017 11:40

Nah!! already committed through 2018, and CEO has suggested that any acquisitions have to be earnings positive. Futher, they have had some rather positives feeds on the drug side over last week or so. Hopefully will fully recover tomorrow's XD date, over next few weeks with sentiment/reality positive and prevailing.

[gbh2] 08/11/2017 11:24

I tend to agree but isn't the current pull back mainly due to the possibility that the Quarterly dividends are looking dubious?

[ny boy] 08/11/2017 10:55

One to buy on decent pull backs and hold for a few years collecting quarterly divis. Imho